Form 4: AMN Healthcare Director James H. Hinton Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director James H. Hinton reports the acquisition of 2,235 Restricted Stock Units (RSUs) in AMN Healthcare Services Inc.

Summary

  • On July 22, 2024, James H. Hinton, a director of AMN Healthcare Services Inc., acquired 2,235 Restricted Stock Units (RSUs).
  • The RSUs were granted under the AMN Healthcare 2017 Equity Plan and represent the contingent right to receive one share of AMN Common Stock per RSU.
  • These RSUs will vest on the earlier of July 22, 2025, or the date of the Company's Annual Meeting of Shareholders in 2025.
  • The RSUs will settle on the date of the director's separation from service with the Company, based on the reporting owner's irrevocable election.
  • The reporting person now directly owns 2,235 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of an equity grant, which is neither particularly positive nor negative.

Positives

  • The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing him to work towards the company's success.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements, but the RSU grant suggests a continued focus on equity-based compensation.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's acquisition of company stock, which is a common practice in corporate governance.

Stakeholder Impact

  • The RSU grant aligns the director's interests with shareholders, potentially leading to decisions that benefit the company's long-term value.
  • The grant has a minor dilutive effect on existing shareholders.

Key Dates

DateDescription
07/22/2024Date of RSU grant and transaction.
07/22/2025Vesting date of RSUs (one year anniversary of grant date).
2025Alternative vesting date: Company's Annual Meeting of Shareholders in 2025.
07/23/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.